Related Experiment Video
Updated: Mar 29, 2026
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Glycogen synthase kinase 3 in Wnt signaling pathway and cancer
Nydia Tejeda-Muñoz1, Martha Robles-Flores1
1Department of Biochemistry, Faculty of Medicine, Universidad Nacional Autónoma de México (UNAM), Mexico, D.F., 04510, México.
Abstract:
Glycogen synthase kinase 3 (GSK-3) was first discovered in 1980 as one of the key enzymes of glycogen metabolism. Since then, GSK-3 has been revealed as one of the master regulators of a diverse range of signaling pathways, including those activated by Wnts, participating in the regulation of numerous cellular functions, suggesting that its activity is tightly regulated. Numerous studies have pointed to an association of GSK-3 dysregulation with the onset and progression of human diseases, including diabetes mellitus, obesity, inflammation, neurological illnesses, and cancer. Therefore, GSK-3 is recognized as an attractive therapeutic target in multiple disorders. However, the great number of substrates that are phosphorylated by GSK-3 has raised the question of whether this limits its feasibility as a therapeutic target because of the potential disruption of many cellular processes and also by the fear that inhibition of GSK-3 may stimulate or aid in malignant transformation, as GSK-3 can phosphorylate pro-oncogenic factors. This mini review focuses on the role played by GSK-3 in Wnt signaling pathway and cancer using as model colon cancer.
Insights
Glycogen synthase kinase 3 (GSK-3) is a key enzyme in cell regulation. Its dysregulation is linked to diseases like cancer, but targeting it therapeutically is complex due to its many roles.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Glycogen synthase kinase 3 (GSK-3) is crucial for glycogen metabolism and Wnt signaling.
- GSK-3 dysregulation is implicated in various diseases, including cancer, diabetes, and neurological disorders.
- Its role as a master regulator of cellular functions necessitates tight control.
Purpose of the Study:
- To review the role of GSK-3 in the Wnt signaling pathway.
- To examine the involvement of GSK-3 in cancer, specifically colon cancer.
- To discuss the therapeutic potential and challenges of targeting GSK-3.
Main Methods:
- Literature review focusing on GSK-3.
- Analysis of GSK-3's role in Wnt signaling.
- Examination of GSK-3's function in colon cancer models.
Main Results:
- GSK-3 is a central player in Wnt pathway regulation.
- Dysfunctional GSK-3 activity is associated with cancer development and progression.
- GSK-3's broad substrate range presents therapeutic challenges and potential oncogenic links.
Conclusions:
- GSK-3 is a significant therapeutic target for various diseases, including cancer.
- Understanding GSK-3's complex roles in signaling pathways is vital for effective drug development.
- Targeting GSK-3 requires careful consideration of its multifaceted functions to avoid adverse effects.
Related Concept Videos
02:54Canonical Wnt Signaling Pathway
02:54Canonical Wnt Signaling Pathway
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
01:41Non-Canonical Wnt Signaling Pathways
01:41Non-Canonical Wnt Signaling Pathways